Crossmark

A hybrid type III effectiveness–implementation study designed to test implementation best practices of deploying a Screen-Triage-Treat approach to cervical cancer screening and management utilizing self-collected HPV DNA testing in Chokwe District, Mozambique

Crossref DOI link: https://doi.org/10.1186/s12889-025-25730-5

Published Online: 2025-11-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Moon, Troy D. https://orcid.org/0000-0002-1637-829X
Salcedo, Mila P.

Mavume-Mangunyane, Elzier

Sidat, Mohsin

Lorenzoni, Cesaltina

Baker, Ellen

Amorim, Gustavo

Paz-Soldán, Valerie A.

Kampa, Kathryn T.

Condon, Kathleen

Myers, Harriett

Sacarlal, Jahit
Funding

Funding for this research was provided by:

National Cancer Institute (U01CA294674)

National Cancer Institute (U01CA294674, P30CA016672)
License Information

Text and Data Mining valid from 2025-11-25

Version of Record valid from 2026-01-03
More Information

Article History

Received: 31 May 2025

Accepted: 17 November 2025

First Online: 25 November 2025

Declarations

:

: Ethics approval for this study was obtained from the Mozambican National Bioethics Committee for Health ( Comité Nacional de Bioética para Saúde , CNBS ) (reference number: 174/CNBS/2025). Any protocol modifications will be submitted for approval by the CNBS and will be communicated to relevant parties. Participants will be enrolled in the study after providing informed consent.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below